Page last updated: 2024-11-03

practolol and Diabetes Mellitus, Type 1

practolol has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, EB1
Lindskov, HO1
Marving, J1
Boesen, F1
Beck-Nielsen, H1
Hesse, B1

Other Studies

1 other study available for practolol and Diabetes Mellitus, Type 1

ArticleYear
Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Danish medical bulletin, 1985, Volume: 32, Issue:3

    Topics: Adrenergic beta-Agonists; Diabetes Mellitus, Type 1; Drug Tolerance; Female; Humans; Hypotension, Or

1985